SynthesisThe Cochrane database of systematic reviews2022
Ocrelizumab for multiple sclerosis.
Mengbing Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled itcites it
SynthesisThe Cochrane database of systematic reviews2022
Mengbing Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.